Stay updated on GARNET: Anti-PD-1 Antibody Clinical Trial

Sign up to get notified when there's something new on the GARNET: Anti-PD-1 Antibody Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GARNET: Anti-PD-1 Antibody Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The study status was updated to Active, not recruiting, with enrollment listed as 738 and a note that the study has 125 locations, and Last Update Posted now appears as Estimated. In addition, contact details and several investigator listings were removed.
    Difference
    15%
    Check dated 2025-10-30T13:29:59.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Major changes: update revision to v3.2.0 and add new operating-status notice and contact details. Deletion of old revision reference v3.0.2. Minor duplication of a phone number remains but updated.
    Difference
    0.6%
    Check dated 2025-10-02T01:23:07.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Core version update from v3.0.2 to v3.1.0 with added support contact details (phone numbers and email).
    Difference
    0.0%
    Check dated 2025-09-30T14:20:25.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; the Back to Top element was removed. No other substantive changes detected.
    Difference
    0.0%
    Check dated 2025-09-16T05:31:05.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.0%
    Check dated 2025-09-09T01:01:50.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, as well as recent research publications related to cancer treatments, particularly focusing on dostarlimab and its applications in various cancers.
    Difference
    4%
    Check dated 2025-09-01T20:54:19.000Z thumbnail image

Stay in the know with updates to GARNET: Anti-PD-1 Antibody Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GARNET: Anti-PD-1 Antibody Clinical Trial page.